Mytos

Mytos has developed and commercialized the iDEM™ platform, which fully automates the manufacture of any human cell type from stem cells. The system is used by leading pharmaceutical and biotech companies to accelerate drug discovery and development workflows. It enables consistent, high-quality production of complex human cells—such as heart or brain cells—from induced pluripotent stem cells within weeks. The platform supports remote monitoring and digital data capture for quality control. Mytos has announced collaborations with major industry players such as Aspen Neuroscience to integrate its automation into advanced cell therapy manufacturing facilities. No clinical results are reported since Mytos is an infrastructure/platform provider.